Albeck M - Search Results

1

Synergistic effect of AS101 and Bryostatin-1 on myeloid leukemia cell differentiation in vitro and in an animal model.

Hayun M, Okun E, Hayun R, Gafter U, Albeck M, Longo DL, Sredni B. Hayun M, et al. Among authors: albeck m. Leukemia. 2007 Jul;21(7):1504-13. doi: 10.1038/sj.leu.2404746. Epub 2007 May 17. Leukemia. 2007. PMID: 17508000

2

Inhibition of the reverse transcriptase activity and replication of human immunodeficiency virus type 1 by AS 101 in vitro.

Vonsover A, Loya S, Sredni B, Albeck M, Gotlieb-Stematsky T, Araf O, Hizi A. Vonsover A, et al. Among authors: albeck m. AIDS Res Hum Retroviruses. 1992 May;8(5):613-23. doi: 10.1089/aid.1992.8.613. AIDS Res Hum Retroviruses. 1992. PMID: 1381205

3

The effect of AS101 on the reconstitution of T-cell reactivity following irradiation or cyclophosphamide treatment.

Kalechman Y, Sotnik-Barkai I, Albeck M, Sredni B. Kalechman Y, et al. Among authors: albeck m. Exp Hematol. 1992 Dec;20(11):1302-8. Exp Hematol. 1992. PMID: 1493859

4

The immunomodulator AS101 administered orally as a chemoprotective and radioprotective agent.

Sredni B, Albeck M, Kazimirsky G, Shalit F. Sredni B, et al. Among authors: albeck m. Int J Immunopharmacol. 1992 May;14(4):613-9. doi: 10.1016/0192-0561(92)90122-2. Int J Immunopharmacol. 1992. PMID: 1521929

5

In vivo synergistic effect of the immunomodulator AS101 and the PKC inducer bryostatin.

Kalechman Y, Albeck M, Sredni B. Kalechman Y, et al. Among authors: albeck m. Cell Immunol. 1992 Aug;143(1):143-53. doi: 10.1016/0008-8749(92)90012-e. Cell Immunol. 1992. PMID: 1623562

6

Use and mechanism of action of AS101 in protecting bone marrow colony forming units-granulocyte-macrophage following purging with ASTA-Z 7557.

Kalechman Y, Barkai IS, Albeck M, Horwith G, Sehagl SN, Sredni B. Kalechman Y, et al. Among authors: albeck m. Cancer Res. 1991 Oct 15;51(20):5614-20. Cancer Res. 1991. PMID: 1913679

7

Protective and restorative role of AS101 in combination with chemotherapy.

Kalechman Y, Albeck M, Oron M, Sobelman D, Gurwith M, Horwith G, Kirsch T, Maida B, Sehgal SN, Sredni B. Kalechman Y, et al. Among authors: albeck m. Cancer Res. 1991 Mar 1;51(5):1499-503. Cancer Res. 1991. PMID: 1997189

8

Synergism between AS101 and PMA in lymphokine production.

Sredni B, Kalechman Y, Shalit F, Albeck M. Sredni B, et al. Among authors: albeck m. Immunology. 1990 Jan;69(1):110-6. Immunology. 1990. PMID: 2107143 Free PMC article.

9

Cytokine secretion effected by synergism of the immunomodulator AS101 and the protein kinase C inducer bryostatin.

Sredni B, Kalechman Y, Albeck M, Gross O, Aurbach D, Sharon P, Sehgal SN, Gurwith MJ, Michlin H. Sredni B, et al. Among authors: albeck m. Immunology. 1990 Aug;70(4):473-7. Immunology. 1990. PMID: 2118479 Free PMC article.

10

The effect of the immunomodulator agent AS101 on interleukin-2 production in systemic lupus erythematosus (SLE) induced in mice by a pathogenic anti-DNA antibody.

Blank M, Sredni B, Albeck M, Mozes E, Shoenfeld Y. Blank M, et al. Among authors: albeck m. Clin Exp Immunol. 1990 Mar;79(3):443-7. doi: 10.1111/j.1365-2249.1990.tb08109.x. Clin Exp Immunol. 1990. PMID: 2317948 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters